Nepal to Participate in Clinical Trials of COVID-19 Treatments MBP134 and Remdesivir
As of July 2, 2026, the World Health Organization (WHO) has officially initiated clinical trials for two investigational therapeutic candidates, MBP134 and remdesivir, to evaluate their efficacy in treating emerging ... Read More